DE3274064D1 - Stabilized insulin preparations and method for their production - Google Patents
Stabilized insulin preparations and method for their productionInfo
- Publication number
- DE3274064D1 DE3274064D1 DE8282301207T DE3274064T DE3274064D1 DE 3274064 D1 DE3274064 D1 DE 3274064D1 DE 8282301207 T DE8282301207 T DE 8282301207T DE 3274064 T DE3274064 T DE 3274064T DE 3274064 D1 DE3274064 D1 DE 3274064D1
- Authority
- DE
- Germany
- Prior art keywords
- production
- insulin preparations
- insulin
- stabilized insulin
- preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 8
- 102000004877 Insulin Human genes 0.000 title abstract 4
- 108090001061 Insulin Proteins 0.000 title abstract 4
- 229940125396 insulin Drugs 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8107423 | 1981-03-10 | ||
| DK414381 | 1981-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3274064D1 true DE3274064D1 (en) | 1986-12-11 |
Family
ID=26067363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8282301207T Expired DE3274064D1 (en) | 1981-03-10 | 1982-03-09 | Stabilized insulin preparations and method for their production |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4472385A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0060141B1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE23269T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU550068B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA1170990A (cg-RX-API-DMAC7.html) |
| CH (1) | CH652031A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE3274064D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES510245A0 (cg-RX-API-DMAC7.html) |
| FI (1) | FI78838C (cg-RX-API-DMAC7.html) |
| FR (1) | FR2501507B1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2094145B (cg-RX-API-DMAC7.html) |
| IE (1) | IE52904B1 (cg-RX-API-DMAC7.html) |
| IT (1) | IT1150639B (cg-RX-API-DMAC7.html) |
| NO (1) | NO157843C (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985002544A1 (en) * | 1983-12-16 | 1985-06-20 | Thomas Takemi Aoki | Insulin delivery algorithm |
| PH23446A (en) * | 1986-10-20 | 1989-08-07 | Novo Industri As | Peptide preparations |
| AU612141B2 (en) * | 1987-02-25 | 1991-07-04 | Novo Nordisk A/S | Novel insulin derivatives |
| US4789660A (en) * | 1987-09-10 | 1988-12-06 | American Home Products Corporation | Insulin administration using methyl and propyl paraben |
| KR100451778B1 (ko) † | 1996-06-20 | 2004-11-16 | 노보 노르디스크 에이/에스 | Nacl을함유하는인슐린제제 |
| ZA984697B (en) * | 1997-06-13 | 1999-12-01 | Lilly Co Eli | Stable insulin formulations. |
| AU1870099A (en) * | 1998-01-09 | 1999-07-26 | Novo Nordisk A/S | Stabilised insulin compositions |
| US20020156434A1 (en) * | 1998-03-13 | 2002-10-24 | Minimed Inc. | Stabilizing catheter for protein drug delivery |
| ATE496064T1 (de) | 2002-05-07 | 2011-02-15 | Novo Nordisk As | Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten |
| US20030226223A1 (en) | 2002-06-11 | 2003-12-11 | The Procter & Gamble Co. | High efficiency electric toothbrush |
| US7322066B2 (en) | 2003-07-16 | 2008-01-29 | Church & Dwight Co., Inc. | Electric toothbrushes having movable, intermittently movable, and fixed bristles |
| US20050053895A1 (en) | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company Attention: Chief Patent Counsel | Illuminated electric toothbrushes emitting high luminous intensity toothbrush |
| US20050050659A1 (en) | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company | Electric toothbrush comprising an electrically powered element |
| FR2896164B1 (fr) * | 2006-01-18 | 2008-07-04 | Flamel Technologies Sa | Formulation colloidale d'insuline longue action et sa preparation |
| FR2943538B1 (fr) * | 2009-03-27 | 2011-05-20 | Adocia | Formulation a action rapide d'insuline recombinante humaine |
| US9018190B2 (en) | 2009-03-27 | 2015-04-28 | Adocia | Functionalized oligosaccharides |
| US20130231281A1 (en) | 2011-11-02 | 2013-09-05 | Adocia | Rapid acting insulin formulation comprising an oligosaccharide |
| US9700599B2 (en) | 2012-11-13 | 2017-07-11 | Adocia | Rapid-acting insulin formulation comprising a substituted anionic compound |
| WO2015120457A1 (en) * | 2014-02-10 | 2015-08-13 | Biodel Inc. | Stabilized ultra-rapid-acting insulin formulations |
| FR3020947B1 (fr) | 2014-05-14 | 2018-08-31 | Adocia | Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations |
| US9795678B2 (en) | 2014-05-14 | 2017-10-24 | Adocia | Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound |
| FR3043557B1 (fr) | 2015-11-16 | 2019-05-31 | Adocia | Composition a action rapide d'insuline comprenant un citrate substitue |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR892194A (fr) * | 1938-06-29 | 1944-03-30 | Ig Farbenindustrie Ag | Procédé de fabrication de préparations à base d'insuline |
| US2474729A (en) * | 1945-01-03 | 1949-06-28 | Rhone Poulenc Sa | Insulin preparations |
| US3102077A (en) * | 1953-08-19 | 1963-08-27 | Christensen Henry Marinus | Preparation of insulin containing 2.75 to 8 percent zinc content |
| DK98342C (da) * | 1959-06-16 | 1964-03-31 | Henry Marinus Dr Christensen | Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation. |
| US4196196A (en) * | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
-
1982
- 1982-03-04 AU AU81114/82A patent/AU550068B2/en not_active Ceased
- 1982-03-09 NO NO820742A patent/NO157843C/no unknown
- 1982-03-09 US US06/356,343 patent/US4472385A/en not_active Expired - Lifetime
- 1982-03-09 IT IT8220038A patent/IT1150639B/it active
- 1982-03-09 CA CA000397937A patent/CA1170990A/en not_active Expired
- 1982-03-09 DE DE8282301207T patent/DE3274064D1/de not_active Expired
- 1982-03-09 FI FI820808A patent/FI78838C/fi not_active IP Right Cessation
- 1982-03-09 ES ES82510245A patent/ES510245A0/es active Granted
- 1982-03-09 GB GB8206899A patent/GB2094145B/en not_active Expired
- 1982-03-09 EP EP82301207A patent/EP0060141B1/en not_active Expired
- 1982-03-09 IE IE536/82A patent/IE52904B1/en not_active IP Right Cessation
- 1982-03-09 AT AT82301207T patent/ATE23269T1/de not_active IP Right Cessation
- 1982-03-09 CH CH1447/82A patent/CH652031A5/de not_active IP Right Cessation
- 1982-03-09 FR FR8203942A patent/FR2501507B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0060141A2 (en) | 1982-09-15 |
| EP0060141A3 (en) | 1983-08-24 |
| FI820808L (fi) | 1982-09-11 |
| IE52904B1 (en) | 1988-04-13 |
| FI78838B (fi) | 1989-06-30 |
| FI78838C (fi) | 1989-10-10 |
| US4472385A (en) | 1984-09-18 |
| NO820742L (no) | 1982-09-13 |
| GB2094145A (en) | 1982-09-15 |
| AU550068B2 (en) | 1986-02-27 |
| FR2501507A1 (cg-RX-API-DMAC7.html) | 1982-09-17 |
| ATE23269T1 (de) | 1986-11-15 |
| ES8302462A1 (es) | 1983-01-16 |
| NO157843C (no) | 1988-06-01 |
| IE820536L (en) | 1982-09-10 |
| CH652031A5 (de) | 1985-10-31 |
| NO157843B (no) | 1988-02-22 |
| IT1150639B (it) | 1986-12-17 |
| CA1170990A (en) | 1984-07-17 |
| IT8220038A0 (it) | 1982-03-09 |
| ES510245A0 (es) | 1983-01-16 |
| GB2094145B (en) | 1984-12-05 |
| FR2501507B1 (cg-RX-API-DMAC7.html) | 1986-04-18 |
| AU8111482A (en) | 1982-09-16 |
| EP0060141B1 (en) | 1986-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2094145B (en) | Stabilized insulin preparations and method for their production | |
| SE8300598D0 (sv) | Stabilized insulin solutions and method for their production | |
| AU3502289A (en) | Method for administering the drug deprenyl so as to minimize the danger of side effects | |
| UA39174C2 (uk) | Асоціати депротонованої гіалуронової кислоти, спосіб одержання асоціатів депротонованої гіалуронової кислоти, фармацевтична композиція та спосіб одержання фармацевтичної композиції | |
| GR970300038T1 (en) | Filtration | |
| ES2043601T3 (es) | Uso de acido gamma-linolenico y compuestos relacionados para la fabricacion de un medicamento para el tratamiento de complicaciones de la diabetes mellitus. | |
| PT85949A (en) | Process for the preparation of insulin compositions containing magnesium ions | |
| AU528310B2 (en) | Composition of paracetamol and metoclopramide | |
| AU3683484A (en) | The use of menthol to enhance transdermal drug delivery | |
| ES460098A1 (es) | Metodo para producir derivados de acido penicilanico. | |
| PT66789B (en) | Process for the preparation of pharmaceutical compositionshaving high rate of resorption from heart glicosides for itself hardly resorptive to be parenterically administered | |
| ES8303086A1 (es) | "un metodo para producir una forma de farmaco para administracion no parenteral a base de l-piroglutamil-l-histidil-l-prolinamida." | |
| DE3065473D1 (en) | Method of stabilizing interferon and composition containing it | |
| DE2963990D1 (en) | Analgesic tablet and process for its preparation | |
| JPS57206608A (en) | Production of gamma-globulin for intravenous injection | |
| IL65445A0 (en) | New derivatives of phenyl aliphatic carboxylic acids,their preparation,their use as medicaments and the compositions containing them | |
| HUT47600A (en) | Process for production of encephalinase glykopeptids, amin acid derivatives with hindering effect and medical compositions containing them | |
| FR2513123B1 (cg-RX-API-DMAC7.html) | ||
| DE3166925D1 (en) | Products prepared from the thymic series factor or from its analogues and derivatives, process for preparation thereof, these products for use as medicines, radioactive tracers obtained from these products and use of these radioactive tracers in dosage processes | |
| EP0239015A3 (en) | Process for producing 1-beta-d-arabinofuranosylcytosine-5'-stearylphosphate monosodium salt and monohydrate thereof, and pharmaceutical composition containing the latter | |
| JPS56167636A (en) | Use of 4-phenyl-4-oxy-2-hydroxybutanoic acid substitution derivative as drug | |
| ES8604731A1 (es) | Un metodo de preparar derivados de 6,11-dihidrodibenz (b,e) oxepina | |
| GB1460325A (en) | Pharmaceutical composition intended for relieving pain and producing analgesia | |
| GB1450598A (en) | Insuling preparations | |
| IT1193615B (it) | Derivati dell'acido acrilico che comprendono un eterociclo contenente ossigeno quali medicinali,prodotti industriali e procedimento di preparazione |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |